0.51
Iovance Biotherapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
0.48
FY23:
0.31
FY24:
0.46
FY25:
0.44
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.27
FY22:
0.18
FY23:
0.47
FY24:
0.45
FY25:
0.47
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.78
FY22:
0.66
FY23:
0.78
FY24:
0.91
FY25:
0.91
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.09
FY23:
0.11
FY24:
0.12
FY25:
0.14
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.07
FY22:
0.07
FY23:
0.09
FY24:
0.08
FY25:
0.08
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.62
FY22:
0.50
FY23:
0.58
FY24:
0.71
FY25:
0.70
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.78
FY22:
0.66
FY23:
0.78
FY24:
0.91
FY25:
0.91
All amounts in billions USD